1471 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Rank Status Study
1 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
2 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
3 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
4 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
5 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
6 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
7 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
8 Not yet recruiting Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
Conditions: Acute HIV Infection;   Antiretroviral Treatment Interruption
Intervention: Other: Treatment interruption
9 Recruiting Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy
Condition: HIV-1 Infection
Intervention: Biological: HIV DNA
10 Not yet recruiting Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV
Conditions: Acute Hepatitis C;   Human Immunodeficiency Virus;   Hepatitis C
Intervention: Drug: Grazoprevir/Elbasvir 100mg/50mg
11 Not yet recruiting Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Conditions: AIDS-Related Non-Hodgkin Lymphoma;   Classical Hodgkin Lymphoma;   HIV Infection;   Kaposi Sarcoma;   Locally Advanced Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Recurrent Hepatocellular Carcinoma;   Recurrent Hodgkin Lymphoma;   Recurrent Kaposi Sarcoma;   Recurrent Malignant Neoplasm;   Recurrent Melanoma;   Recurrent Melanoma of the Skin;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Non-Small Cell Lung Carcinoma;   Refractory Hodgkin Lymphoma;   Refractory Malignant Neoplasm;   Solid Neoplasm;   Stage IIIA Hepatocellular Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Skin Melanoma;   Stage IIIB Hepatocellular Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Skin Melanoma;   Stage IIIC Hepatocellular Carcinoma;   Stage IIIC Skin Melanoma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Skin Melanoma;   Stage IVA Hepatocellular Carcinoma;   Stage IVB Hepatocellular Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
12 Not yet recruiting Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: Placebo for VRC01;   Drug: Antiretroviral therapy (ART) (regimen will vary within countries and by patient)
13 Completed Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.
Condition: Acquired Immunodeficiency Syndrome
Intervention: Drug: Tenofovir disoproxil fumarate and emtricitabine
14 Completed A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection
Condition: HIV Infections
Intervention: Drug: Enfuvirtide
15 Not yet recruiting Vaginal Antibody Safety Trial: Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV)
Conditions: HIV;   Herpes Simplex Infections
Interventions: Drug: MB66;   Drug: Placebo Film
16 Recruiting Targeting Platelets in Chronic HIV Infection
Condition: HIV-1 Infection
Interventions: Drug: Clopidogrel;   Drug: Aspirin;   Drug: Placebo
17 Not yet recruiting Antiviral Pharmacology and Adherence in Drug Users
Conditions: HEPATITIS C;   Virus, Human Immunodeficiency
Interventions: Behavioral: Directly Observed Therapy;   Behavioral: Wirelessly Observed Therapy
18 Not yet recruiting A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients
Conditions: Human Immunodeficiency Virus;   Dolutegravir;   Monotherapy;   Treatment Efficacy
Intervention: Drug: Dolutegravir
19 Completed Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men
Conditions: Human Immunodeficiency Virus (HIV);   Sexually Transmitted Disease (STD)
Interventions: Behavioral: STAND HIV Risk Reduction Intervention;   Behavioral: Text Messaging Intervention
20 Recruiting A Sleep Program to Improve Sleep Quality in People With HIV
Conditions: HIV - Human Immunodeficiency Virus;   Insomnia Disorder
Intervention: Behavioral: Digital cognitive behavioural therapy for insomnia (dCBT-I)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years